This article is more than 5 years old. Information may no longer be current.

Trial Scorecard: FIGHT

Issue: September 2016

Add topic to email alerts

Please provide your email address to receive an email when new articles are posted on Inflammatory Bowel Disease.

Subscribe

Added to email alerts

You've successfully added Inflammatory Bowel Disease to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added Inflammatory Bowel Disease to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Study of subcutaneous injection of liraglutide (Victoza, Novo Nordisk) vs. placebo on outcomes in patients hospitalized for HF with reduced ejection fraction.